Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Real World Study With Benralizumab in Severe Asthma in Switzerland
- Status
- COMPLETED
- Phase
- N/A
A Scintigraphy Study of PT010 in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE1
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma
- Status
- UNKNOWN
- Phase
- N/A
A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D)
- Status
- UNKNOWN
- Phase
- PHASE2
Distributed Registry
- Status
- COMPLETED
- Phase
- N/A
Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
- Status
- UNKNOWN
- Phase
- PHASE4
Prevalence of Asthma and Allergies Among Children in UAE
- Status
- COMPLETED
- Phase
- N/A
DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE3
DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE3
Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Improve Checkpoint-blockade Response in Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Metastatic Breast Cancer in Austria
- Status
- RECRUITING
- Phase
- N/A